Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Avogaro

Showing results (191-200 of 426) with videos related to

Pageof 43
Sort By:
Diabetes Research and Clinical Practice|April 19, 2025
Corrigendum to "Exploring the benefits of alirocumab as lipid-lowering therapy in people with diabetes and very high cardiovascular risk" [Diabetes Res. Clin. Pract. 222 (2025) 112055]Angelo Avogaro, Raffaella Buzzetti, Riccardo Candido, et al.
Atherosclerosis|June 22, 2015
Diabetes modifies the relationships among carotid plaque calcification, composition and inflammationLisa Menegazzo, Nicol Poncina, Mattia Albiero, et al.
Diabetes Care|May 27, 2004
Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjectsAngelo Avogaro, Richard M Watanabe, Alessandra Dall'Arche, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 17, 2011
Hemodynamics assessed via approximate entropy analysis of impedance cardiography time series: effect of metabolic syndromeStefania Guerra, Federico Boscari, Angelo Avogaro, et al.
Acta Diabetologica|October 3, 2013
Monocyte-macrophage polarization balance in pre-diabetic individualsGian Paolo Fadini, Roberta Cappellari, Marta Mazzucato, et al.
Journal of Diabetes and Its Complications|October 8, 2020
Estradiol correlates with erectile dysfunction and its severity in type 2 diabetic patientsMaurizio De Rocco Ponce, Andrea Garolla, Nicola Caretta, et al.
Cardiovascular Diabetology|December 10, 2022
Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine careMario Luca Morieri, Enrico Longato, Barbara Di Camillo, et al.
Diabetes Care|March 1, 2006
Endothelial progenitor cells and the diabetic paradoxGian Paolo Fadini, Saverio Sartore, Ilenia Baesso, et al.
The Lancet. Diabetes & Endocrinology|October 1, 2022
Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life historyAngelo Avogaro, Saula Vigili de Kreutzenberg, Mario Luca Morieri, et al.
Metabolic Brain Disease|June 8, 2017
Cognitive, neurophysiologic and metabolic sequelae of previous hypoglycemic coma revealed by hyperinsulinemic-hypoglycemic clamp in type 1 diabetic patientsAlberto Maran, Cristina Crepaldi, Franco Del Piccolo, et al.
Pageof 43

Showing results (191-200 of 426) with videos related to

Sort By:
Pageof 43
Diabetes Research and Clinical Practice|April 19, 2025
Corrigendum to "Exploring the benefits of alirocumab as lipid-lowering therapy in people with diabetes and very high cardiovascular risk" [Diabetes Res. Clin. Pract. 222 (2025) 112055]Angelo Avogaro, Raffaella Buzzetti, Riccardo Candido, et al.
Atherosclerosis|June 22, 2015
Diabetes modifies the relationships among carotid plaque calcification, composition and inflammationLisa Menegazzo, Nicol Poncina, Mattia Albiero, et al.
Diabetes Care|May 27, 2004
Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjectsAngelo Avogaro, Richard M Watanabe, Alessandra Dall'Arche, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 17, 2011
Hemodynamics assessed via approximate entropy analysis of impedance cardiography time series: effect of metabolic syndromeStefania Guerra, Federico Boscari, Angelo Avogaro, et al.
Acta Diabetologica|October 3, 2013
Monocyte-macrophage polarization balance in pre-diabetic individualsGian Paolo Fadini, Roberta Cappellari, Marta Mazzucato, et al.
Journal of Diabetes and Its Complications|October 8, 2020
Estradiol correlates with erectile dysfunction and its severity in type 2 diabetic patientsMaurizio De Rocco Ponce, Andrea Garolla, Nicola Caretta, et al.
Cardiovascular Diabetology|December 10, 2022
Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine careMario Luca Morieri, Enrico Longato, Barbara Di Camillo, et al.
Diabetes Care|March 1, 2006
Endothelial progenitor cells and the diabetic paradoxGian Paolo Fadini, Saverio Sartore, Ilenia Baesso, et al.
The Lancet. Diabetes & Endocrinology|October 1, 2022
Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life historyAngelo Avogaro, Saula Vigili de Kreutzenberg, Mario Luca Morieri, et al.
Metabolic Brain Disease|June 8, 2017
Cognitive, neurophysiologic and metabolic sequelae of previous hypoglycemic coma revealed by hyperinsulinemic-hypoglycemic clamp in type 1 diabetic patientsAlberto Maran, Cristina Crepaldi, Franco Del Piccolo, et al.
Pageof 43